EVALUATION STUDIES, FDA PHASE 3
\ɪvˌaljuːˈe͡ɪʃən stˈʌdɪz], \ɪvˌaljuːˈeɪʃən stˈʌdɪz], \ɪ_v_ˌa_l_j_uː_ˈeɪ_ʃ_ə_n s_t_ˈʌ_d_ɪ_z]\
Sort: Oldest first
-
Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
By DataStellar Co., Ltd
Nearby Words
- evaluation studies [pt]
- evaluation studies [publication type]
- evaluation studies, drug, preclinical
- evaluation studies, fda phase 1
- evaluation studies, fda phase 2
- Evaluation Studies, FDA Phase 3
- evaluation studies, fda phase 4
- evaluation studies, fda phase i
- evaluation studies, fda phase ii
- evaluation studies, fda phase iii
- evaluation studies, fda phase iv